An update on emerging anti-amyloid-β monoclonal antibodies for treating Alzheimer's disease: the role of apolipoprotein E

Madia Lozupone; Vittorio Dibello; Antonio Daniele; Francesco Panza

doi:10.1080/14728214.2025.2481847

An update on emerging anti-amyloid-β monoclonal antibodies for treating Alzheimer's disease: the role of apolipoprotein E

Madia Lozupone
, Vittorio Dibello
, Antonio Daniele
, Francesco Panza^*

^*Corresponding author

University of Bari

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	77-81
Number of pages	5
Journal	Expert Opinion on Emerging Drugs
Volume	30
Issue number	2
DOIs	https://doi.org/10.1080/14728214.2025.2481847
Publication status	Published - 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Pharmacology
Pharmacology (medical)

Keywords

ARIA
Alzheimer’s disease
amyloid-β
apolipoprotein E
cerebrospinal fluid
mild cognitive impairment

Access to Document

10.1080/14728214.2025.2481847

Cite this

@article{918c388546a14e88bfe8f3eefa618db9,

title = "An update on emerging anti-amyloid-β monoclonal antibodies for treating Alzheimer's disease: the role of apolipoprotein E",

keywords = "ARIA, Alzheimer{\textquoteright}s disease, amyloid-β, apolipoprotein E, cerebrospinal fluid, mild cognitive impairment, ARIA, Alzheimer{\textquoteright}s disease, amyloid-β, apolipoprotein E, cerebrospinal fluid, mild cognitive impairment",

author = "Madia Lozupone and Vittorio Dibello and Antonio Daniele and Francesco Panza",

year = "2025",

doi = "10.1080/14728214.2025.2481847",

language = "English",

volume = "30",

pages = "77--81",

journal = "Expert Opinion on Emerging Drugs",

issn = "1472-8214",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - An update on emerging anti-amyloid-β monoclonal antibodies for treating Alzheimer's disease: the role of apolipoprotein E

AU - Lozupone, Madia

AU - Dibello, Vittorio

AU - Daniele, Antonio

AU - Panza, Francesco

PY - 2025

Y1 - 2025

KW - ARIA

KW - Alzheimer’s disease

KW - amyloid-β

KW - apolipoprotein E

KW - cerebrospinal fluid

KW - mild cognitive impairment

KW - ARIA

KW - Alzheimer’s disease

KW - amyloid-β

KW - apolipoprotein E

KW - cerebrospinal fluid

KW - mild cognitive impairment

UR - https://publicatt.unicatt.it/handle/10807/319456

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=105001155486&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105001155486&origin=inward

U2 - 10.1080/14728214.2025.2481847

DO - 10.1080/14728214.2025.2481847

M3 - Article

SN - 1472-8214

VL - 30

SP - 77

EP - 81

JO - Expert Opinion on Emerging Drugs

JF - Expert Opinion on Emerging Drugs

IS - 2

ER -

An update on emerging anti-amyloid-β monoclonal antibodies for treating Alzheimer's disease: the role of apolipoprotein E

UN SDGs

All Science Journal Classification (ASJC) codes

Keywords

Access to Document

Other files and links

Cite this